The Latest Cardiac and Vascular News
Seasoned medtech executive to scale up the Company’s organizational development upon the increase in demand for the evaluative installations of the PURE EP System™ Westport, CT, Feb. 16, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal […]
Westport, CT, Feb. 02, 2021 (GLOBE NEWSWIRE) — Global market for AI in healthcare is estimated to reach $45.2 billion by 2026 BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac […]
Westport, CT, Jan. 27, 2021 (GLOBE NEWSWIRE) — Company to provide corporate overview and progress on the rollout of the PURE EP™ System BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and […]
Westport, CT, Jan. 14, 2021 (GLOBE NEWSWIRE) — Leading industry publication calls attention to ongoing challenges in the electrophysiology lab PURE EP System is highlighted as a novel technological solution BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and […]
PURE EP(tm) system evaluation conducted under the leadership of Cardiologists Vinod Chauhan, M.D. and Deepak Gaba, M.D. Memorial Hospital is nationally recognized for its emphasis on innovation. Westport, CT, Jan. 12, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform […]
NeuroClear is set to commence experiments aimed at developing therapies for autonomic nervous system disease Westport, CT, Dec. 18, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG […]
Sale Marks Milestone for Company’s Commercial expansion at leading Center of Excellence Westport, CT, Dec. 11, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today […]
First Patient Cases with PURE EP System Conducted at Deborah Heart and Lung Center Westport, CT, Oct. 29, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and […]
Westport, CT, Oct. 28, 2020 (GLOBE NEWSWIRE) — Company’s PURE EP™ System’s data-driven commercialization is gaining acceptance through new evaluative installations at medical centers of excellence The strongest cash balance in its history positions the Company well to execute on its strategic goals. BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology […]
Positive responses confirm that the PURE EP signals are preferred to conventional sources of intracardiac signals in a blinded, independent analysis. Abstract concludes PURE EP™ System is able to produce reliable and high-quality signals when compared to the available standard of care systems. Westport, CT, Sept. 15, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) […]
